The Center for Vaccine Development at the University of Maryland’s School of Medicine received a $4 million grant from The Wellcome Trust, considered among the most prestigious grant-giving charitable foundations.
The Center for Vaccine Development (CVD) and Indian partner Bharat Biotech will use the grant for pre-clinical and clinical research for a vaccine that fights an infectious disease stemming from non-typhoidal Salmonella. The disease is common in sub-Saharan Africa and can lead to meningitis and sepsis.